Teva Pharmaceutical Industries (TEVA) Liabilities and Shareholders Equity (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) recorded Liabilities and Shareholders Equity of $39.86 billion in Q2 2026, down 0.7% from $40.13 billion a year earlier and down 0.5% from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Teva Pharmaceutical Industries reported Liabilities and Shareholders Equity of $40.75 billion, up 3.6% from FY2024.
- Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of -4.3% (FY2020 to FY2025).
- Across earlier years, Liabilities and Shareholders Equity came in at $39.33 billion in FY2024 (-9.6%), $43.48 billion in FY2023 (-1.2%), $44.01 billion in FY2022 (-7.7%) and $47.67 billion in FY2021 (-5.9%).
- Quarterly Liabilities and Shareholders Equity has ranged from $38.42 billion in Q1 2025 to $47.85 billion in Q3 2021 over the past five years.
- On a year-over-year basis, Liabilities and Shareholders Equity rose in two of the last eight quarters, with an average decline of 2.6%.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 4.2% in Q1 2026, against a decline of 10.2% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $40.04 billion (Q1 2026), $40.75 billion (Q4 2025) and $39.86 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Teva Pharmaceutical Industries | 48.14 Bn | 34.98 Bn | 2.15 Bn | 39.86 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.86 Bn |
| Mar 31, 2026 | 40.04 Bn |
| Dec 31, 2025 | 40.75 Bn |
| Sep 30, 2025 | 39.86 Bn |
| Jun 30, 2025 | 40.13 Bn |
| Mar 31, 2025 | 38.42 Bn |
| Dec 31, 2024 | 39.33 Bn |
| Sep 30, 2024 | 41.76 Bn |
| Jun 30, 2024 | 41.34 Bn |
| Mar 31, 2024 | 42.77 Bn |
| Dec 31, 2023 | 43.48 Bn |
| Sep 30, 2023 | 42.10 Bn |
| Jun 30, 2023 | 43.10 Bn |
| Mar 31, 2023 | 43.46 Bn |
| Dec 31, 2022 | 44.01 Bn |
| Sep 30, 2022 | 44.25 Bn |
| Jun 30, 2022 | 45.93 Bn |
| Mar 31, 2022 | 47.06 Bn |
| Dec 31, 2021 | 47.67 Bn |
| Sep 30, 2021 | 47.85 Bn |
API Access
Teva Pharmaceutical Industries Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();